Skip to Navigation | Skip to Content
Post

Pfizer-BioNTech Vaccine Is Effective Against South African Variant, New Research Shows
The Wall Street Journal

The Covid-19 vaccine from Pfizer Inc. and BioNTech SE was shown to generate protection against the variant first identified in South Africa in laboratory testing, according to research published Wednesday on the New England Journal of Medicine website.